Company intelligence / Profile preview

Sonde Health

Boston, Massachusetts, United Statessondehealth.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

Clinically validated vocal biomarker tech using AI to detect/manage key conditions via voice analysis. Pilots/studies ongoing with leading institutions.

Therapeutic areas: PulmonologyPsychiatryNeurologyInfectious Diseases
Modalities: Device (voice-enabled apps and devices)Non-pharmacological therapy (digital biomarker monitoring)Platform (AI/machine learning-based vocal biomarker analysis)
Industry: Digital Health Medical Devices

Partnerships

GN Group (hearing aid manufacturer)U.S. Air Force/AFWERX SBIR programMassachusetts General HospitalAlbert Einstein College of Medicine

Beyond the preview

Go deeper on Sonde Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonde Health.

Explore the full profile